Amlodipine And Valsartan Tablet, Film Coated
Product Images NDC 46708-458

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Amlodipine And Valsartan (NDC 46708-458). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Alembic Pharmaceuticals Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

30's Bottle Label (Amlovalsartan 10 160mg)

30's Bottle Label (Amlovalsartan 10 160mg)
Amlodipine and Valsartan Tablets are a prescription medication that contains 13.9 mg amlodipine besylate USP and 160 mg valsartan USP, equivalent to 10 mg amlodipine, as active ingredients. The recommended dosage can be found in the package insert. The tablets should be stored at temperatures between 15-30°C, away from moisture and out of children's reach. The tablets are manufactured in India by Alembic Pharmaceuticals Limited at the Village Panelav, P.O. Tajpura, Near Baska, Taluka-Halol, Panchmahal 389350. Each pack contains 30 tablets and the batch number and expiry date are also provided.*
FDA Label Image

30's Bottle Pack (Amlovalsartan 10 320)

30's Bottle Pack (Amlovalsartan 10 320)
This is a description of a medication called Amlodipine and Valsartan Tablets, USP with each tablet containing 139 mg of amlodipine besylate USP equivalent to 10 mg of amlodipine, and 320 mg of valsartan USP. The recommended dosage is provided on the package insert, and the tablets should be stored between 15-30°C, protected from moisture, and out of reach of children. The medication is manufactured by Alembic Pharmaceuticals Limited and comes in a package of 30 tablets. The batch and license number are also provided.*
FDA Label Image

30's Bottle Pack (Amlovalsartan 5 160)

30's Bottle Pack (Amlovalsartan 5 160)
Each tablet contains a combination of amlodipine besylate and valsartan, used to treat high blood pressure. The tablet has 6.9mg amlodipine besylate equivalent to 5mg amlodipine and 160mg of valsartan USP. The recommended dosage is available in the package insert. The medicine should be stored at 25°C (77°F) and protected from excursions permitted to 15-30°C (59-86°F). It is essential to protect from moisture and keep out of reach of children. The manufacturer of the medicine is Alembic Pharmaceuticals Limited, formulated in Village Panelav, P. . Tajpura, Near Baska, Taluka-Halol, Panchmahal 389350, Gujarat, India. The product is available in a cardboard box with 30 tablets, and the item meets prescription requirements. Batch and Expiry details are not available.*
FDA Label Image

30's Bottle Label (Amlovalsartan 5 320mg)

30's Bottle Label (Amlovalsartan 5 320mg)
Amlodipine and Valsartan Tablets, USP is a medication that consists of 6.9 mg of amlodipine besylate USP equivalent to 5 mg of amodipine and 320 mg of valsartan USP. The usual dosage can be found in the package insert. This medication should be stored at 25°C (77°F) with excursions permitted to 15-30°C (59-86°F) and protected from moisture. It is important to keep this and all drugs out of reach of children. The manufacturer of this medication is Alembic Pharmaceutcals Limited located in Gujarat, India. The NDC number for this medication is 46708-460-30 and it comes in a 30 tablets package.*
FDA Label Image

Amlodipine Besylate (Amlovalsartan Str1)

FDA Label Image

Valsartan (Amlovalsartan Str2)

FDA Label Image

Figure 1 (Amlovalsartanl Figure1)

Figure 1 (Amlovalsartanl Figure1)
This is a graph that illustrates the probability of achieving systolic blood pressure (SBP) lower than 140 mmHg using different medications such as Amlodipine and Valsartan Tablets, placebo, and others. The x-axis shows the baseline SBP values ranging from 140 mmHg to 180 mmHg, and the y-axis indicates the probability percentage.*
FDA Label Image

Figure 2 (Amlovalsartanl Figure2)

Figure 2 (Amlovalsartanl Figure2)
This appears to be a graph showing the probability of achieving Diastolic Blood Pressure (DBP) below 90 mmHg using Amlodipine and Valsartan Tablets, 320 mg and placebo. The data is displayed for weeks 8 and at Baseline DBP (mmHg).*
FDA Label Image

Figure 3 (Amlovalsartanl Figure3)

Figure 3 (Amlovalsartanl Figure3)
This is a product description of Amlodipine and Valsartan Tablets, USP with varying dosage strengths. A graph shows the probability of achieving systolic blood pressure <130 mmHg at Week 8, based on baseline SBP (mmHg).*
FDA Label Image

Figure 4 (Amlovalsartanl Figure4)

Figure 4 (Amlovalsartanl Figure4)
This text describes the probability of achieving a diastolic blood pressure below 80 mmHg at week 8 when using a tablet called Anlodipine and Valsartan. The tablet contains 320 mg of Valsartan and 10 mg of Amlodipine. The graph indicates the probability of achieving such pressure based on the baseline value.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.